# A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes

> **NCT01053377** · PHASE4 · UNKNOWN · sponsor: **National Institute for Public Health and the Environment (RIVM)** · enrollment: 900 (estimated)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Tamiflu (verum)
- **DRUG:** Tamiflu placebo

## Key facts

- **NCT ID:** NCT01053377
- **Lead sponsor:** National Institute for Public Health and the Environment (RIVM)
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2010-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01053377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01053377, "A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01053377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*